{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:39Z","timestamp":1792701639323,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05453-1","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:28:34Z","timestamp":1792654114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral spray sildenafil in erectile dysfunction: current evidence and clinical perspectives"],"prefix":"10.1007","author":[{"given":"Massimiliano","family":"Raffo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Di Naro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Carbotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nocera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Della Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno Roberto","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"5453_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41443-025-01016-7","volume":"37","author":"L Boeri","year":"2025","unstructured":"Boeri L, Palumbo F, Cai T, Miacola C, Ceruti C, Bitelli M et al (2025) Sildenafil oral suspension formulation for erectile dysfunction: is it love at first sight? Int J Impot Res 37:937\u2013938. https:\/\/doi.org\/10.1038\/s41443-025-01016-7","journal-title":"Int J Impot Res"},{"key":"5453_CR2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41443-025-01019-4","volume":"37","author":"L Boeri","year":"2025","unstructured":"Boeri L, Graps G, Zino E, Zago A, Li Puma A, Ciamarra F et al (2025) Effectiveness and patient satisfaction with the new sildenafil oral suspension formulation compared to sildenafil oro-dispersible film: a real-life study. Int J Impot Res 37:902\u2013907. https:\/\/doi.org\/10.1038\/s41443-025-01019-4","journal-title":"Int J Impot Res"},{"key":"5453_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081848","volume":"10","author":"F De Leonardis","year":"2022","unstructured":"De Leonardis F, Colalillo G, Finazzi Agr\u00f2 E, Miano R, Fuschi A, Asimakopoulos AD (2022) Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines 10:1848. https:\/\/doi.org\/10.3390\/biomedicines10081848","journal-title":"Biomedicines"},{"key":"5453_CR4","doi-asserted-by":"publisher","first-page":"29M","DOI":"10.1016\/j.amjcard.2005.07.008","volume":"96","author":"AL Burnett","year":"2005","unstructured":"Burnett AL (2005) Phosphodiesterase 5 mechanisms and therapeutic applications. Am J Cardiol 96:29M-31M. https:\/\/doi.org\/10.1016\/j.amjcard.2005.07.008","journal-title":"Am J Cardiol"},{"key":"5453_CR5","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.esxm.2021.100453","volume":"9","author":"P Sangkum","year":"2021","unstructured":"Sangkum P, Sirisopana K, Matang W, Phengsalae Y, Lertsithichai P, Ketsuwan C et al (2021) Efficacy of the orally disintegrating strip sildenafil for the treatment of erectile dysfunction: a prospective, randomized trial. Sex Med 9:100453. https:\/\/doi.org\/10.1016\/j.esxm.2021.100453","journal-title":"Sex Med"},{"key":"5453_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/sm2.31","volume":"2","author":"A Carvalheira","year":"2014","unstructured":"Carvalheira A, Forjaz V, Pereira NM (2014) Adherence to phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction in long-term users: how do men use the inhibitors? Sex Med 2:96\u2013102. https:\/\/doi.org\/10.1002\/sm2.31","journal-title":"Sex Med"},{"key":"5453_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ijcp.12074","volume":"67","author":"WB Smith","year":"2013","unstructured":"Smith WB, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ (2013) PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract 67:768\u2013780. https:\/\/doi.org\/10.1111\/ijcp.12074","journal-title":"Int J Clin Pract"},{"key":"5453_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1742-1241.2009.02254.x","volume":"64","author":"F Giuliano","year":"2010","unstructured":"Giuliano F, Jackson G, Montorsi F, Martin-Morales A, Raillard P (2010) Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract 64:240\u2013255. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02254.x","journal-title":"Int J Clin Pract"},{"issue":"Suppl 1","key":"5453_CR9","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/sj.ijir.3901205","volume":"16","author":"JD Corbin","year":"2004","unstructured":"Corbin JD (2004) Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res 16(Suppl 1):S4-7. https:\/\/doi.org\/10.1038\/sj.ijir.3901205","journal-title":"Int J Impot Res"},{"key":"5453_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ijir.2008.4","volume":"20","author":"SH Francis","year":"2008","unstructured":"Francis SH, Morris GZ, Corbin JD (2008) Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function. Int J Impot Res 20:333\u2013342. https:\/\/doi.org\/10.1038\/ijir.2008.4","journal-title":"Int J Impot Res"},{"key":"5453_CR11","first-page":"407","volume":"38","author":"SA Huang","year":"2013","unstructured":"Huang SA, Lie JD (2013) Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction. P T Peer-Rev J Formul Manag 38:407\u2013419","journal-title":"P T Peer-Rev J Formul Manag"},{"key":"5453_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091266","volume":"16","author":"AK ElHady","year":"2023","unstructured":"ElHady AK, El-Gamil DS, Abdel-Halim M, Abadi AH (2023) Advancements in phosphodiesterase 5 inhibitors: unveiling present and future perspectives. Pharmaceuticals 16:1266. https:\/\/doi.org\/10.3390\/ph16091266","journal-title":"Pharmaceuticals"},{"key":"5453_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/pharmaceutics17050563","volume":"17","author":"AI Malykhina","year":"2025","unstructured":"Malykhina AI, Efimova SS, Ostroumova OS (2025) Membrane-mediated action of phosphodiesterase 5 inhibitors. Pharmaceutics 17:563. https:\/\/doi.org\/10.3390\/pharmaceutics17050563","journal-title":"Pharmaceutics"},{"key":"5453_CR14","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1097\/MJT.0000000000000302","volume":"24","author":"E Dadey","year":"2017","unstructured":"Dadey E (2017) Bioequivalence of 2 formulations of sildenafil oral soluble film 100 mg and sildenafil citrate (Viagra) 100 mg oral tablets in healthy male volunteers. Am J Ther 24:e373\u2013e380. https:\/\/doi.org\/10.1097\/MJT.0000000000000302","journal-title":"Am J Ther"},{"key":"5453_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2147\/DDDT.S124034","volume":"11","author":"M Radicioni","year":"2017","unstructured":"Radicioni M, Castiglioni C, Giori A, Cupone I, Frangione V, Rovati S (2017) Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers. Drug Des Devel Ther 11:1183\u20131192. https:\/\/doi.org\/10.2147\/DDDT.S124034","journal-title":"Drug Des Devel Ther"},{"key":"5453_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5414\/CP201995","volume":"52","author":"E-Y Kim","year":"2014","unstructured":"Kim E-Y, Lee SY, Jeon J-Y, Im Y-J, Kim Y, Kim HI et al (2014) Pharmacokinetics of a new orally soluble film formulation of sildenafil administered without water. Int J Clin Pharmacol Ther 52:437\u2013445. https:\/\/doi.org\/10.5414\/CP201995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"5453_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clinthera.2013.02.006","volume":"35","author":"H Roh","year":"2013","unstructured":"Roh H, Son H, Lee D, Yeon KJ, Kim HS, Kim H et al (2013) Pharmacokinetic comparison of an orally disintegrating film formulation with a film-coated tablet formulation of sildenafil in healthy Korean subjects: a randomized, open-label, single-dose, 2-period crossover study. Clin Ther 35:205\u2013214. https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.006","journal-title":"Clin Ther"},{"key":"5453_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00059","volume":"9","author":"L De Toni","year":"2018","unstructured":"De Toni L, De Rocco Ponce M, Franceschinis E, Dall\u2019Acqua S, Padrini R, Realdon N et al (2018) Sublingual administration of sildenafil oro-dispersible film: new profiles of drug tolerability and pharmacokinetics for PDE5 inhibitors. Front Pharmacol 9:59. https:\/\/doi.org\/10.3389\/fphar.2018.00059","journal-title":"Front Pharmacol"},{"key":"5453_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40261-018-0665-x","volume":"38","author":"L Loprete","year":"2018","unstructured":"Loprete L, Leuratti C, Frangione V, Radicioni M (2018) Pharmacokinetics of a novel sildenafil orodispersible film administered by the supralingual and the sublingual route to healthy men. Clin Drug Investig 38:765\u2013772. https:\/\/doi.org\/10.1007\/s40261-018-0665-x","journal-title":"Clin Drug Investig"},{"key":"5453_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","volume":"14","author":"RC Rosen","year":"2002","unstructured":"Rosen RC, Cappelleri JC, Gendrano N (2002) The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14:226\u2013244. https:\/\/doi.org\/10.1038\/sj.ijir.3900857","journal-title":"Int J Impot Res"},{"key":"5453_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/ppa.s3349","volume":"3","author":"AA Raheem","year":"2009","unstructured":"Raheem AA, Kell P (2009) Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil. Patient Prefer Adherence 3:99\u2013104. https:\/\/doi.org\/10.2147\/ppa.s3349","journal-title":"Patient Prefer Adherence"},{"key":"5453_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28248038","volume":"28","author":"M Stielow","year":"2023","unstructured":"Stielow M, Witczy\u0144ska A, Kubry\u0144 N, Fija\u0142kowski \u0141, Nowaczyk J, Nowaczyk A (2023) The bioavailability of drugs-the current state of knowledge. Molecules 28:8038. https:\/\/doi.org\/10.3390\/molecules28248038","journal-title":"Molecules"},{"key":"5453_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/sexmed\/qfac007","volume":"11","author":"A Sansone","year":"2023","unstructured":"Sansone A, Frangione V, Lanzarotti A, Cocci A, Ceruti C, De Sio M et al (2023) Effect of the new 75-mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study. Sex Med 11:qfac007. https:\/\/doi.org\/10.1093\/sexmed\/qfac007","journal-title":"Sex Med"},{"key":"5453_CR24","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.juro.2006.07.019","volume":"176","author":"SE Althof","year":"2006","unstructured":"Althof SE, O\u2019Leary MP, Cappelleri JC, Crowley AR, Tseng L-J, Collins S (2006) Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. J Urol 176:2132\u20132137. https:\/\/doi.org\/10.1016\/j.juro.2006.07.019","journal-title":"J Urol"},{"key":"5453_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.urology.2006.05.047","volume":"68","author":"G Jackson","year":"2006","unstructured":"Jackson G, Montorsi P, Cheitlin MD (2006) Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. Urology 68:47\u201360. https:\/\/doi.org\/10.1016\/j.urology.2006.05.047","journal-title":"Urology"},{"key":"5453_CR26","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jsxm.2017.10.066","volume":"14","author":"A Cocci","year":"2017","unstructured":"Cocci A, Capece M, Cito G, Russo GI, Falcone M, Timpano M et al (2017) Effectiveness and safety of oro-dispersible sildenafil in a new film formulation for the treatment of erectile dysfunction: comparison between sildenafil 100-mg film-coated tablet and 75-mg oro-dispersible film. J Sex Med 14:1606\u20131611. https:\/\/doi.org\/10.1016\/j.jsxm.2017.10.066","journal-title":"J Sex Med"},{"key":"5453_CR27","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02905-8","volume":"25","author":"V Mewada","year":"2024","unstructured":"Mewada V, Shah J, Jacob S, Shah H, Boddu SHS, Nair AB (2024) Improvement of bioavailability of sildenafil citrate through taste masked orodispersible film for pulmonary hypertension management. AAPS PharmSciTech 25:194. https:\/\/doi.org\/10.1208\/s12249-024-02905-8","journal-title":"AAPS PharmSciTech"},{"key":"5453_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/10717544.2014.916763","volume":"23","author":"KM Hosny","year":"2016","unstructured":"Hosny KM, El-Say KM, Ahmed OA (2016) Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. Drug Deliv 23:355\u2013361. https:\/\/doi.org\/10.3109\/10717544.2014.916763","journal-title":"Drug Deliv"},{"issue":"Suppl 1","key":"5453_CR29","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1046\/j.0306-5251.2001.00029.x","volume":"53","author":"GJ Muirhead","year":"2002","unstructured":"Muirhead GJ, Wilner K, Colburn W, Haug-Pihale G, Rouviex B (2002) The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil. Br J Clin Pharmacol 53(Suppl 1):21S-30S. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.00029.x","journal-title":"Br J Clin Pharmacol"},{"key":"5453_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2125.2000.00245.x","volume":"50","author":"GJ Muirhead","year":"2000","unstructured":"Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N (2000) Pharmacokinetic interactions between sildenafil and saquinavir\/ritonavir. Br J Clin Pharmacol 50:99\u2013107. https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00245.x","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 9A","key":"5453_CR31","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/s0002-9343(00)00656-2","volume":"109","author":"RA Kloner","year":"2000","unstructured":"Kloner RA (2000) Sex and the patient with cardiovascular risk factors: focus on sildenafil. Am J Med 109(Suppl 9A):13S-21S. https:\/\/doi.org\/10.1016\/s0002-9343(00)00656-2","journal-title":"Am J Med"},{"key":"5453_CR32","doi-asserted-by":"publisher","first-page":"26M","DOI":"10.1016\/s0002-9149(02)03368-4","volume":"92","author":"RG Brindis","year":"2003","unstructured":"Brindis RG, Kloner RA (2003) Sildenafil in patients with cardiovascular disease. Am J Cardiol 92:26M-36M. https:\/\/doi.org\/10.1016\/s0002-9149(02)03368-4","journal-title":"Am J Cardiol"},{"key":"5453_CR33","doi-asserted-by":"publisher","first-page":"35C","DOI":"10.1016\/s0002-9149(99)00046-6","volume":"83","author":"RM Zusman","year":"1999","unstructured":"Zusman RM, Morales A, Glasser DB, Osterloh IH (1999) Overall cardiovascular profile of sildenafil citrate. Am J Cardiol 83:35C-44C. https:\/\/doi.org\/10.1016\/s0002-9149(99)00046-6","journal-title":"Am J Cardiol"},{"key":"5453_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ph14040365","volume":"14","author":"A Ouranidis","year":"2021","unstructured":"Ouranidis A, Tsiaxerli A, Vardaka E, Markopoulou CK, Zacharis CK, Nicolaou I et al (2021) Sildenafil 4.0-integrated synthetic chemistry, formulation and analytical strategies effecting immense therapeutic and societal impact in the fourth industrial era. Pharmaceuticals (Basel) 14:365. https:\/\/doi.org\/10.3390\/ph14040365","journal-title":"Pharmaceuticals (Basel)"},{"key":"5453_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/ciia.2006.1.4.403","volume":"1","author":"K Hatzimouratidis","year":"2006","unstructured":"Hatzimouratidis K (2006) Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence. Clin Interv Aging 1:403\u2013414. https:\/\/doi.org\/10.2147\/ciia.2006.1.4.403","journal-title":"Clin Interv Aging"},{"key":"5453_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70257","author":"M Raffo","year":"2026","unstructured":"Raffo M, Corsini C, Pozzi E, Negri F, Birolini G, Bertini A et al (2026) Unveiling treatment adherence gaps in psychogenic versus organic erectile dysfunction. Andrology. https:\/\/doi.org\/10.1111\/andr.70257","journal-title":"Andrology"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05453-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05453-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05453-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:03:01Z","timestamp":1792699381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05453-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":36,"alternative-id":["5453"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05453-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"13 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}